189 related articles for article (PubMed ID: 9293960)
1. Enhanced preservation of acutely ischemic myocardium and improved clinical outcomes using glucose-insulin-potassium (GIK) solutions.
Lazar HL
Am J Cardiol; 1997 Aug; 80(3A):90A-93A. PubMed ID: 9293960
[TBL] [Abstract][Full Text] [Related]
2. Limiting ischemic myocardial damage using glucose-insulin-potassium solutions.
Lazar HL; Zhang X; Rivers S; Bernard S; Shemin RJ
Ann Thorac Surg; 1995 Aug; 60(2):411-6. PubMed ID: 7646105
[TBL] [Abstract][Full Text] [Related]
3. Enhanced preservation of acutely ischemic myocardium using glucose-insulin-potassium solutions.
Lazar HL
J Card Surg; 1994 May; 9(3 Suppl):474-8. PubMed ID: 8069039
[TBL] [Abstract][Full Text] [Related]
4. [Glucose-insulin-potassium (GIK) in the reduction of acute myocardial ischemia after an aortocoronary bypass intervention].
Dainese L; Polvani GL; Fumero A; Spirito R; Alamanni F; Agrifoglio M; Parolari A; Biglioli P
G Ital Cardiol; 1999 May; 29(5):575-9; discussion 580-2. PubMed ID: 10367228
[No Abstract] [Full Text] [Related]
5. Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation.
Sack MN; Yellon DM
J Am Coll Cardiol; 2003 Apr; 41(8):1404-7. PubMed ID: 12706939
[TBL] [Abstract][Full Text] [Related]
6. Glucose, insulin and potassium (GIK) during reperfusion mediates improved myocardial bioenergetics.
Angelos MG; Murray HN; Gorsline RT; Klawitter PF
Resuscitation; 2002 Dec; 55(3):329-36. PubMed ID: 12458070
[TBL] [Abstract][Full Text] [Related]
7. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events.
Lazar HL; Chipkin SR; Fitzgerald CA; Bao Y; Cabral H; Apstein CS
Circulation; 2004 Mar; 109(12):1497-502. PubMed ID: 15006999
[TBL] [Abstract][Full Text] [Related]
8. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.
Selker HP; Beshansky JR; Sheehan PR; Massaro JM; Griffith JL; D'Agostino RB; Ruthazer R; Atkins JM; Sayah AJ; Levy MK; Richards ME; Aufderheide TP; Braude DA; Pirrallo RG; Doyle DD; Frascone RJ; Kosiak DJ; Leaming JM; Van Gelder CM; Walter GP; Wayne MA; Woolard RH; Opie LH; Rackley CE; Apstein CS; Udelson JE
JAMA; 2012 May; 307(18):1925-33. PubMed ID: 22452807
[TBL] [Abstract][Full Text] [Related]
9. Myocardial protection of insulin and potassium in a porcine ischemia-reperfusion model.
Oates A; Nubani R; Smiley J; Kistler L; Hughey S; Theiss P; Perez-Tamayo RA; Eiferman D; Lonchyna V; Higgins RS
Surgery; 2009 Jul; 146(1):23-30. PubMed ID: 19541007
[TBL] [Abstract][Full Text] [Related]
10. High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in patients with acute myocardial infarction.
Zhang L; Zhang L; Li YH; Zhang HY; Chen ML; Gao MM; Hu AH; Yang HS; Yang HS
Eur J Clin Invest; 2005 Mar; 35(3):164-70. PubMed ID: 15733070
[TBL] [Abstract][Full Text] [Related]
11. Modified Glucose-Insulin-Potassium Regimen Provides Cardioprotection With Improved Tissue Perfusion in Patients Undergoing Cardiopulmonary Bypass Surgery.
Zhao K; Zhang Y; Li J; Cui Q; Zhao R; Chen W; Liu J; Zhao B; Wan Y; Ma XL; Yu S; Yi D; Gao F
J Am Heart Assoc; 2020 Mar; 9(6):e012376. PubMed ID: 32151220
[TBL] [Abstract][Full Text] [Related]
12. Glucose-insulin-potassium therapy in the era of coronary revascularization.
Leos CL; Griego JE; Anderson JR
Cardiol Rev; 2005; 13(5):266-70. PubMed ID: 16106190
[TBL] [Abstract][Full Text] [Related]
13. Glucose-insulin-potassium therapy in adult patients undergoing cardiac surgery: a meta-analysis.
Fan Y; Zhang AM; Xiao YB; Weng YG; Hetzer R
Eur J Cardiothorac Surg; 2011 Jul; 40(1):192-9. PubMed ID: 21075642
[TBL] [Abstract][Full Text] [Related]
14. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting.
Ranasinghe AM; Quinn DW; Pagano D; Edwards N; Faroqui M; Graham TR; Keogh BE; Mascaro J; Riddington DW; Rooney SJ; Townend JN; Wilson IC; Bonser RS
Circulation; 2006 Jul; 114(1 Suppl):I245-50. PubMed ID: 16820580
[TBL] [Abstract][Full Text] [Related]
15. Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting.
Lazar HL; Philippides G; Fitzgerald C; Lancaster D; Shemin RJ; Apstein C
J Thorac Cardiovasc Surg; 1997 Feb; 113(2):354-60; discussion 360-2. PubMed ID: 9040630
[TBL] [Abstract][Full Text] [Related]
16. [Therapy with glucose-insulin-potassium reduces the complications in the acute phase of myocardial infarct. Arguments against].
Arós F; Loma-Osorio A
Rev Esp Cardiol; 1998 Sep; 51(9):727-31. PubMed ID: 9803798
[TBL] [Abstract][Full Text] [Related]
17. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.
Mehta SR; Yusuf S; Díaz R; Zhu J; Pais P; Xavier D; Paolasso E; Ahmed R; Xie C; Kazmi K; Tai J; Orlandini A; Pogue J; Liu L;
JAMA; 2005 Jan; 293(4):437-46. PubMed ID: 15671428
[TBL] [Abstract][Full Text] [Related]
18. Metabolic therapy in cardiac surgery--"Optimizing the engine's fuel supply and more...".
Doenst T; Amorim PA
Scand Cardiovasc J; 2010 Feb; 44(1):4-8. PubMed ID: 20141343
[No Abstract] [Full Text] [Related]
19. Safety and efficacy of glucose-insulin-potassium treatment in coronary artery bypass graft surgery and percutaneous coronary intervention.
Ali-Hassan-Sayegh S; Mirhosseini SJ; Zeriouh M; Dehghan AM; Shahidzadeh A; Karimi-Bondarabadi AA; Sabashnikov A; Popov AF
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):667-76. PubMed ID: 26265069
[TBL] [Abstract][Full Text] [Related]
20. Metabolic intervention for the ischemic and post-ischemic heart.
Svedjeholm R; Håkanson E; Szabó Z
Wien Klin Wochenschr; 1999 Jul; 111(13):501-11. PubMed ID: 10444803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
